Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06485687 · ClinicalTrials.gov registry record · NA
Low Intensity Focused Ultrasound for Binge Eating Disorder
A NA study of Binge-Eating Disorder, sponsored by Ali Rezai.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06485687: Active NA study of Binge-Eating Disorder, sponsored by Ali Rezai.
NCT06485687 is a NA study of Binge-Eating Disorder that is active but no longer recruiting, run by Ali Rezai. The registered enrollment target is 15 participants, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06485687, a NA study of Binge-Eating Disorder, is active but no longer recruiting, sponsored by Ali Rezai.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with Binge Eating Disorder (BED)
Primary Outcome
All adverse events that are related to LIFU procedure will be assessed
Conditions Studied
Interventions
- DEVICE LIFU Neuromodulation
Study Locations (1)
West Virginia
- West Virginia University: Rockefeller Neuroscience Institute - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-10-31 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT06485687 still lists
NCT06485687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Binge-Eating Disorder appearing as the primary indexed condition, and to 1 intervention - of which LIFU Neuromodulation is the first listed.
NCT06485687 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT06485687 about?
NCT06485687 is a clinical study titled "Low Intensity Focused Ultrasound for Binge Eating Disorder". This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with Binge Eating Disorder (BED)
What is the current status of trial NCT06485687?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-10-31. Estimated completion is 2027-12-31.
What conditions does trial NCT06485687 study?
This clinical trial studies the following conditions: Binge-Eating Disorder.
What interventions are being tested in trial NCT06485687?
The interventions under investigation include: LIFU Neuromodulation (DEVICE).
Who is sponsoring clinical trial NCT06485687?
This trial is sponsored by Ali Rezai, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06485687 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Binge-Eating Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06485687's enrollment target sits among peer trials
15 36th of 37 higher than 2 of 37 other Binge-Eating Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Binge-Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
-
Treating Binge Eating and Obesity Digitally in Black Women
RECRUITING · NA
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
RECRUITING · NA
-
Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI